Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
CPT: Pharmacometrics & Systems Pharmacology · 2023
DOI: 10.1002/psp4.12913 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2023. Verfasst von Abdullah Al Shoyaib und 10 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Maryland, Silver…. Hauptthemen laut MEDLINE: Research Report, Models, Biological. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This workshop report summarizes the presentations and panel discussion related to the use of physiologically based pharmacokinetic (PBPK) modeling approaches for food effect assessment, collected from Session 2 of Day 2 of the workshop titled “Regulatory Utility of Mechanistic Modeling to Support Alternative Bioequivalence Approaches.” The US Food and Drug Administration in collaboration with the Center for Research on Complex Generics organized this workshop where this particular session titled “Oral PBPK for Evaluating the Impact of Food on BE” presented successful cases of PBPK modeling approaches for food effect assessment. Recently, PBPK modeling has started to gain popularity among academia, industries, and regulatory agencies for its potential utility during bioavailability (BA) and/or bioequivalence (BE) studies of new and generic drug products to assess the impact of food on BA/BE. Considering the promises of PBPK modeling in generic drug development, the aim of this workshop session was to facilitate knowledge sharing among academia, industries, and regulatory agencies to understand the knowledge gap and guide the path forward. This report collects and summarizes the information presented and discussed during this session to disseminate the information into a broader audience for further advancement in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Maryland, Silver Spring, USA.
- Bristol Myers Squibb, Princeton, New Jersey, USA.
- Amneal Pharmaceuticals, Bridgewater, New Jersey, USA.
- Office of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
- Research Innovation Center Basel, Roche, Basel, Switzerland.
- Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID-Profile: Rebeka Jereb
Zitieren
APA
Al Shoyaib, A., Riedmaier, A. E., Kumar, A., Roy, P., Parrott, N. J., Fang, L., Tampal, N., Yang, Y., Jereb, R., Zhao, L., & Wu, F. (2023). Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.12913
Vancouver
Al Shoyaib A, Riedmaier AE, Kumar A, Roy P, Parrott NJ, Fang L, et al. Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report. CPT: Pharmacometrics & Systems Pharmacology. 2023. doi:10.1002/psp4.12913
BibTeX
@article{AlShoyaib2023,
author = {Al Shoyaib, Abdullah and Riedmaier, Arian Emami and Kumar, Anita and Roy, Partha and Parrott, Neil John and Fang, Lanyan and Tampal, Nilufer and Yang, Yuching and Jereb, Rebeka and Zhao, Liang and Wu, Fang},
title = {Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2023},
doi = {10.1002/psp4.12913}
}
EUVIMED